🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 02/12/1992 | 0,1193 USD |
| 31/08/1992 | 0,1193 USD |
| 02/06/1992 | 0,1097 USD |
| 02/03/1992 | 0,1097 USD |
| 02/12/1991 | 0,1002 USD |
| 30/08/1991 | 0,1002 USD |
| 03/06/1991 | 0,0891 USD |
| 04/03/1991 | 0,0891 USD |
| 03/12/1990 | 0,0891 USD |
| 28/08/1990 | 0,0891 USD |
| 29/05/1990 | 0,0716 USD |
| 05/03/1990 | 0,0716 USD |
| 04/12/1989 | 0,0716 USD |
| 29/08/1989 | 0,0716 USD |
| 30/05/1989 | 0,0652 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/04/2009 | 25,32 | 25,35 | 24,82 | 25,07 | -1,50% | 2,11% | 13.959.779 |
| 06/04/2009 | 25,08 | 26,28 | 25,08 | 25,45 | +0,79% | 4,79% | 13.312.430 |
| 03/04/2009 | 25,76 | 26,06 | 24,90 | 25,25 | -2,00% | 4,52% | 16.227.232 |
| 02/04/2009 | 25,96 | 26,34 | 25,23 | 25,76 | +0,04% | 4,26% | 18.833.608 |
| 01/04/2009 | 25,28 | 25,98 | 24,57 | 25,75 | +0,90% | 5,59% | 18.880.244 |
| 31/03/2009 | 25,58 | 25,84 | 25,31 | 25,52 | +0,75% | 2,09% | 22.948.370 |
| 30/03/2009 | 25,55 | 25,67 | 24,94 | 25,33 | -2,25% | 2,84% | 15.245.256 |
| 27/03/2009 | 25,70 | 26,36 | 25,57 | 25,92 | -1,52% | 3,05% | 17.048.340 |
| 26/03/2009 | 26,50 | 26,54 | 25,84 | 26,32 | +0,29% | 2,63% | 16.516.061 |
| 25/03/2009 | 26,68 | 26,74 | 25,58 | 26,24 | -0,90% | 4,33% | 18.255.950 |
| 24/03/2009 | 26,35 | 26,83 | 26,25 | 26,48 | -0,82% | 2,21% | 15.464.917 |
| 23/03/2009 | 25,95 | 26,70 | 25,54 | 26,70 | +4,72% | 4,45% | 20.397.014 |
| 20/03/2009 | 25,40 | 25,95 | 25,11 | 25,50 | +2,61% | 3,34% | 26.895.977 |
| 19/03/2009 | 25,79 | 25,90 | 24,50 | 24,85 | -3,41% | 5,40% | 25.223.683 |
| 18/03/2009 | 25,10 | 26,24 | 24,93 | 25,73 | +1,32% | 5,21% | 22.185.531 |
| 17/03/2009 | 24,82 | 25,42 | 24,62 | 25,39 | +1,53% | 3,23% | 23.637.326 |
| 16/03/2009 | 25,74 | 26,18 | 24,92 | 25,01 | -3,18% | 4,89% | 34.252.203 |
| 13/03/2009 | 23,15 | 26,43 | 23,15 | 25,83 | +12,65% | 14,18% | 60.001.249 |
| 12/03/2009 | 20,86 | 22,99 | 20,67 | 22,93 | +9,53% | 11,12% | 40.235.864 |
| 11/03/2009 | 21,13 | 21,69 | 20,80 | 20,94 | -1,17% | 4,20% | 29.498.685 |
| 10/03/2009 | 20,64 | 21,29 | 20,41 | 21,18 | +5,76% | 4,25% | 36.396.411 |
| 09/03/2009 | 19,23 | 21,47 | 19,13 | 20,03 | -7,70% | 12,16% | 88.189.724 |
| 06/03/2009 | 21,33 | 21,89 | 21,03 | 21,70 | +2,71% | 4,03% | 18.906.130 |
| 05/03/2009 | 21,56 | 21,84 | 20,93 | 21,13 | -4,45% | 4,25% | 21.628.205 |
| 04/03/2009 | 22,15 | 22,45 | 21,41 | 22,11 | +0,52% | 4,70% | 22.605.674 |
| 03/03/2009 | 22,60 | 23,00 | 21,81 | 21,99 | -1,66% | 5,24% | 18.975.402 |
| 02/03/2009 | 22,73 | 23,21 | 22,35 | 22,37 | -3,14% | 3,78% | 17.418.808 |
| 27/02/2009 | 24,30 | 24,60 | 23,06 | 23,09 | -7,07% | 6,32% | 34.071.738 |
| 26/02/2009 | 26,88 | 26,88 | 24,84 | 24,85 | -6,70% | 7,60% | 20.846.816 |
| 25/02/2009 | 26,90 | 27,15 | 26,45 | 26,63 | -2,17% | 2,59% | 22.865.054 |